Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1BTK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,125
Award facts
- Contract value 100% obligated
- $25,124.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,124.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on January 15, 2026, with completion expected by January 16, 2026. TYPHIM VI is a typhoid vaccine used by the Department of Defense to protect military personnel against typhoid fever. This is a non-set-aside contract awarded through open competition, with performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The prime IDC enables the contractor to supply a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support the Defense Health Agency and other federal healthcare systems worldwide. AmerisourceBergen's consistent receipt of competitive awards across multiple therapeutic domains demonstrates its established capability to fulfill critical medical supply requirements for the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F1BTK?
SPE2DR26F1BTK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F1BTK worth?
The government has obligated $25,125 on SPE2DR26F1BTK.
Is contract SPE2DR26F1BTK an order under another contract?
Yes. SPE2DR26F1BTK is a delivery order under SPE2DR25D2012, an indefinite delivery contract.
Was contract SPE2DR26F1BTK competed?
The extent of competition for SPE2DR26F1BTK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award